Lv1
48 积分 2026-01-14 加入
Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma
5小时前
待确认
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
5小时前
已完结
Myosteatosis and the survival of patients with hepatocellular carcinoma: a meta-analysis
5小时前
已完结
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
3个月前
已完结
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
5个月前
已完结
The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review
5个月前
已完结
Role of circulating-tumor DNA in the early-stage non-small cell lung carcinoma as a predictive biomarker
7个月前
已完结
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
